A PET imaging study of 5-HT1A receptors in cat brain after acute and chronic fluoxetine treatment

NeuroImage

Volumn 33, Issue 3, 2006, Pages 834-842

  Aznavour, Nicolas ^a,b   Rbah, Latifa ^a,b   Riad, Mustapha ^c   Reilhac, Anthonin ^b   Costes, Nicolas ^b   Descarries, Laurent ^c   Zimmer, Luc ^a,b  

^a UNIVERSITÉ LYON 1   (France)

^b CERMEP IMAGERIE DU VIVANT   (France)

^c UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Antidepressants; Brain imaging; Internalization; SSRI treatment

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; FLUOXETINE; SEROTONIN 1A RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CHRONIC DRUG ADMINISTRATION; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DRUG BINDING SITE; DRUG BRAIN LEVEL; DRUG EFFECT; DRUG RECEPTOR BINDING; IMMUNOELECTRON MICROSCOPY; IN VIVO STUDY; INTERNALIZATION; MALE; NEUROIMAGING; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; RECEPTOR SOLUBILIZATION;

EID: 33750067381     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2006.08.012     Document Type: Article

References (67)

1. Adell A., and Artigas F. Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. Naunyn-Schmiedeberg's Arch. Pharmacol. 343 (1991) 237-244
2. 1A receptor binding sites in the cat brain. J. Chem. Neuroanat. 31 (2006) 226-232
3. 3H]8-OH-DPAT and increases the effect of raphe stimulation on 5-HT metabolism. Eur. J. Pharmacol. 178 (1990) 179-197
4. Bel N., and Artigas F. Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study. Eur. J. Pharmacol. 229 (1992) 101-103
5. Bel N., and Artigas F. Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse 15 (1993) 243-245
6. Blier P., and de Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol. Sci. 15 (1994) 220-226
7. Blier P., de Montigny C., and Tardif D. Effects of the two antidepressant drugs mianserin and indalpine on the serotonergic system: single-cell studies in the rat. Psychopharmacology 84 (1984) 242-249
8. Brix G., Zaers J., Adam L.E., Bellemann M.E., Ostertag H., Trojan H., Haberkorn U., Doll J., Oberdorfer F., and Lorenz W.J. Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association. J. Nucl. Med. 38 (1997) 1614-1623
9. 1A agonists alnespirone (S-20499) and 8-OH-DPAT on extracellular 5-hydroxytryptamine in different regions of rat brain. Br. J. Pharmacol. 122 (1997) 733-741
10. 1A receptors in rat brain. Neuropharmacology 44 (2003) 93-101
11. 3H]8-OH-DPAT. Biog. Amines 13 (1997) 217-232
12. 18F]MPPF positron emission tomography kinetics for the determination of 5-hydroxytryptamine(1A) receptor concentration with multiinjection. J. Cereb. Blood Flow Metab. 22 (2002) 753-765
13. 1A receptor binding in men and women over aging. J. Nucl. Med. 46 (2005) 1980-1989
14. Czachura J.F., and Rasmussen K. Effects of acute and chronic administration of fluoxetine on the activity of serotonergic neurons in the dorsal raphe nucleus of the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 362 (2000) 266-275
15. 1A receptor antibodies in rabbits injected with a synthetic peptide. Neurosci. Lett. 118 (1990) 189-192
16. Elsinga P.H., Hendrikse N.H., Bart J., Vaalburg W., and van Waarde A. PET studies on P glycoprotein function in the blood-brain barrier: how it affects uptake and binding of drugs within the CNS. Curr. Pharm. Des. 10 (2004) 1493-1503
17. 1A receptors. Synapse 35 (2000) 192-200
18. 11C]raclopride binding in anesthetized cats. Neuropsychopharmacology 27 (2002) 72-84
19. 11C]-DASB, a tool for in vivo measurement of SSRI-induced occupancy of the serotonin transporter: PET characterization and evaluation in cats. Synapse 47 (2003) 123-133
20. 1A binding: a PET study in monkeys. NeuroImage 28 (2005) 238-248
21. 1A receptors in rat brain membranes. Eur. J. Pharmacol. 288 (1995) 173-186
22. Gunn R.N., Lammertsma A.A., Hume S.P., and Cunningham V.J. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. NeuroImage 4 (1997) 279-287
23. 1A receptor ligand [carbonyl-11C]WAY-100635 for PET. NeuroImage 8 (1998) 426-440
24. 1A receptors. J. Neurosci. 18 (1998) 10150-10156
25. Hamon M., Fattaccini C.M., Adrien J., Gallissot M.C., Martin P., and Gozlan H. Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties. J. Pharmacol. Exp. Ther. 246 (1988) 745-752
26. 11C]raclopride binding in the striatum of the awake cat: effects of anaesthetics and role of cerebral blood flow. Eur. J. Nucl. Med. 30 (2003) 141-148
27. 1A receptor-G protein interactions in brain following chronic antidepressant administration. Neuropsychopharmacology 26 (2002) 565-573
28. Hervás I., and Artigas F. Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors. Eur. J. Pharmacol. 358 (1998) 9-18
29. Hjorth S., and Auerback S.B. Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors. Eur. J. Pharmacol. 260 (1994) 251-255
30. Hjorth S., and Magnusson T. The 5-HT1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo. Naunyn-Schmiedeberg's Arch. Pharmacol. 338 (1988) 463-471
31. Hutson P.H., Sarna G.S., O'Connell M.T., and Curzon G. Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OH-DPAT into the nucleus raphe dorsalis. Neurosci. Lett. 100 (1989) 276-280
32. 1A receptor radioligands to determine receptor density and changes in endogenous 5-HT. Synapse 59 (2006) 330-341
33. 1A receptors in rats treated chronically with a novel antidepressant, cericlamine. J. Pharmacol. Exp. Ther. 268 (1994) 1432-1443
34. 1A receptor antagonist. Brain Res. 673 (1995) 217-225
35. 1A presynaptic, but not postsynaptic receptor-mediated responses: relationship to antidepressant-like action. Eur. J. Pharmacol. 138 (1987) 53-60
36. Kia H.K., Miquel M.C., Brisorgueil M.J., Daval G., Riad M., El Mestikawy S., Hamon M., and Vergé D. Immunocytochemical localization of serotonin1A receptors in the rat central nervous system. J. Comp. Neurol. 365 (1996) 289-305
37. Kreiss D.S., and Lucki I. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J. Pharmacol. Exp. Ther. 274 (1995) 866-876
38. 18F]MPPF, a fluoro analog of WAY-100635. Nucl. Med. Biol. 25 (1998) 343-350
39. 1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn-Schmiedeberg's Arch. Pharmacol. 352 (1995) 141-148
40. 1B receptors and 5-HT transporter in rats treated chronically with fluoxetine. Neuropharmacology 39 (2000) 110-122
41. 1A receptors in the rat brain. Fundam. Clin. Pharmacol. 15 (2001) 71
42. 11C]WAY-100635 in humans: comparison of arterial and reference tissue input functions. J. Cereb. Blood Flow Metab. 20 (2000) 1111-1133
43. Parsey R.V., Oquendo M.A., Ogden R.T., Olvet D.M., Simpson N., Huang Y.Y., Van Heertum R.L., Arango V., and Mann J.J. Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study. Biol. Psychiatry 59 (2006) 106-113
44. 1A receptor binding potential during a major depressive episode predicts poor treatment response: preliminary data from a naturalistic study. Neuropsychopharmacology 31 (2006) 1745-1749
45. 1A receptors as measured by [(35)S]-GTP gamma S autoradiography. Br. J. Pharmacol. 135 (2002) 1115-1122
46. 1A receptors in vivo. In: King F.D., and Oxford A.W. (Eds). Progress in Medicinal Chemistry vol. 38 (2001), Elsevier Science, Oxford 189-247
47. Piñeyro G., and Blier P. Autoregulation of serotonin neurons: role in antidepressant drug action. Pharmacol. Rev. 51 (1999) 533-591
48. Piñeyro G., Blier P., Dennis P., and de Montigny C. Desensitization of the neuronal 5-HT carrier following its long-term blockade. J. Neurosci. 14 (1994) 3036-3047
49. 18F-MPPF by the electrically evoked serotonin release in the rat hippocampus. Synapse 49 (2003) 239-245
50. 1A autoreceptors by desensitized receptors in nucleus raphe dorsalis of rat. FENS Forum, Vienna, Austria; online.
51. 1B serotonin receptors in adult rat brain. J. Comp. Neurol. 417 (2000) 181-194
52. Riad M., Watkins K.C., Doucet E., Hamon M., and Descarries L. Agonist-induced internalization of serotonin-1A receptors in the dorsal raphe nucleus (autoreceptors) but not hippocampus (heteroreceptors). J. Neurosci. 21 (2001) 8378-8386
53. 18F-MPPF in the nucleus raphe dorsalis of rat. J. Neurosci. 24 (2004) 5420-5426
54. Rutter J.J., and Auerbach S.B. Acute uptake inhibition increases extracellular serotonin in the rat forebrain. J. Pharmacol. Exp. Ther. 265 (1993) 1319-1324
55. Rutter J.J., Gundlah C., and Auerbach S.B. Systemic uptake inhibition decreases serotonin release via somatodendritic receptor activation. Synapse 20 (1995) 225-233
56. 2 and other G-linked receptors. Synapse 50 (2003) 35-40
57. 1A receptors to 8-OH-DPAT: an in vivo spinal reflex study. NeuroReport 8 (1997) 2489-2493
58. Sharp T., Branwell S.R., and Grahame-Smith D.G. 5-HT1 agonists reduce 5-hydroxytryptamine release in rat hippocampus in vivo as determined by brain microdialysis. Br. J. Pharmacol. 96 (1989) 283-290
59. 35S]GTP gamma S binding in rat brain regions. Neuropharmacology 42 (2002) 1031-1038
60. Snyder R.S., and Niemer W.T. A Stereotaxic Atlas of the Cat Brain (1961), University of Chicago Press
61. 1A autoreceptors on serotoninergic neurons in the midbrain raphe nuclei. Eur. J. Neurosci. 2 (1990) 1144-1154
62. 1B agonists. Synapse 1 (1987) 3-9
63. Stockmeier C.A., Shapiro L.A., Dilley G.E., Kolli T.N., Friedman L., and Rajkowska G. Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. J. Neurosci. 18 (1998) 7394-7401
64. 18F]MPPF binding in rat brain: fenfluramine vs the combination of citalopram and ketanserin. Neuropsychopharmacology 30 (2005) 1624-1631
65. Wiklund L., Léger L., and Persson M. Monoamine cell distribution in the cat brain stem. A fluorescence histochemical study with quantification of indolaminergic and locus coeruleus cell groups. J. Comp. Neurol. 203 (1981) 613-647
66. 18F]MPPF binding in the rat dorsal raphe nucleus. Eur. J. Nucl. Med. 29 (2002) 1237-1247
67. 1A autoreceptor internalization. NeuroImage 22 (2004) 1421-1426